Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06373016 · ClinicalTrials.gov registry record · NA
Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder
A NA study of Bipolar Disorder and Bipolar Disorder Type 1, sponsored by Stony Brook University.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 3
- Study locations
NCT06373016 is a NA study of Bipolar Disorder and Bipolar Disorder Type 1 that is actively recruiting participants, run by Stony Brook University. The registered enrollment target is 100 participants, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (70% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT06373016, a NA study of Bipolar Disorder and Bipolar Disorder Type 1, is actively recruiting participants, sponsored by Stony Brook University.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this clinical trial is to test how specific components of diet affect brain function and behavior for individuals with bipolar. The main question it aims to answer is how glucose and ketones each affect the brain's response to risk and reward. Participants will be asked to provide blood (to assess baseline measures of how the body uses energy), and then to receive two MRI scan sessions, on separate days. During each MRI scan session, participants will play three games, from which they can win money, before and after drinking glucose (on one day) or ketones (on the other day). Investigators will compare individuals with and without bipolar to test whether the two groups differ in how their brains use energy, and to test how the brain's use of energy affects behavior.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Glucose
- DIETARY_SUPPLEMENT Ketones
Study Locations (3)
Massachusetts
- McLean Hospital - Belmont
- Martinos Center for Biomedical Research, Building 149, 13th Street - Charlestown
New York
- Laufer Center for Physical and Quantitative Biology , Stony Brook University - Stony Brook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-01-26 |
| Est. Completion | 2027-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06373016
The ClinicalTrials.gov registry entry for NCT06373016 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 332-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (70% lower). The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Bipolar Disorder appearing as the primary indexed condition, and to 2 interventions - of which Glucose is the first listed.
NCT06373016 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT06373016 about?
NCT06373016 is a clinical study titled "Use of Ketosis in Modulating Metabolic Pathways in Bipolar Disorder". The goal of this clinical trial is to test how specific components of diet affect brain function and behavior for individuals with bipolar. The main question it aims to answer is how glucose and ketones each affect the brain's response to risk and reward. Participants will be asked to provide blood ...
What is the current status of trial NCT06373016?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-01-26. Estimated completion is 2027-02-01.
What conditions does trial NCT06373016 study?
This clinical trial studies the following conditions: Bipolar Disorder, Bipolar Disorder Type 1.
What interventions are being tested in trial NCT06373016?
The interventions under investigation include: Glucose (DIETARY_SUPPLEMENT), Ketones (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06373016?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06373016 being conducted?
This trial has 3 study locations across Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder
RECRUITING · NA
-
Healthy Lifestyles in Bipolar Disorder: Bay Area Study
RECRUITING · NA
-
A Future Thinking Intervention for Comorbid Tobacco Use Disorder and Bipolar Disorder
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.